GlassScriptPhysician profile
Barton Sanders
NPI 1740667005
$3,660.35
in general payments reported to CMS, 2019-2025
48 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what 96% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
See the full distribution for Hospice and Palliative Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $237 · 2023: $1,059 · 2024: $1,003 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,423.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $273.50 | 2023-2025 | |
| Janssen Biotech, INC. | $242.99 | 2022-2025 | Darzalex, Imbruvica, Tecvayli |
| Merck Sharp & Dohme LLC | $229.28 | 2022-2025 | Keytruda, Welireg |
| Astrazeneca Pharmaceuticals LP | $200.72 | 2023-2025 | Calquence, Tagrisso, Imfinzi |
| Aveo Pharmaceuticals, INC. | $178.77 | 2022-2025 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $163.16 | 2023-2025 | Libtayo |
| Abbvie INC. | $161.67 | 2023-2025 | Venclexta |
| Daiichi Sankyo INC. | $149.27 | 2023-2025 | Enhertu |
| Eisai INC. | $126.75 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.00 | 2024 | Relistor |
| Exelixis INC. | $112.11 | 2022-2025 | Cabometyx |
| Genentech USA, INC. | $104.73 | 2023-2025 | Polivy, Tecentriq, Venclexta |
| Jazz Pharmaceuticals INC. | $95.78 | 2023-2025 | Vyxeos |
| Takeda Pharmaceuticals U.S.A., INC. | $90.51 | 2023-2025 | Ninlaro, Iclusig |
| Gilead Sciences, INC. | $87.17 | 2023-2024 | Trodelvy |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $83.60 | 2023-2025 | Brukinsa, Tevimbra |
| Lilly USA, LLC | $76.13 | 2023-2025 | Retevmo, Verzenio, Jaypirca |
| Blueprint Medicines Corporation | $73.83 | 2023-2025 | Ayvakit |
| Tersera Therapeutics LLC | $69.59 | 2023-2025 | Zoladex, Xermelo |
| Puma Biotechnology, INC. | $69.43 | 2022-2024 | |
| Emd Serono, INC. | $63.17 | 2023-2025 | Tepmetko, Bavencio |
| Pfizer INC. | $62.18 | 2023-2024 | |
| Pharmaessentia USA Corporation | $61.50 | 2024-2025 | Besremi |
| Astellas Pharma US INC | $59.85 | 2023-2025 | Xtandi, Padcev, Vyloy |
| Karyopharm Therapeutics INC. | $48.84 | 2023 | Xpovio |
| Taiho Oncology, INC. | $45.32 | 2023-2025 | |
| Array Biopharma INC | $44.21 | 2023 | Mektovi, Braftovi, Paxlovid |
| Glaxosmithkline, LLC. | $42.46 | 2025 | Zejula, Jemperli, Ojjaara |
| Morphosys, US INC. | $42.04 | 2023 | Monjuvi |
| Alexion Pharmaceuticals, INC. | $37.31 | 2022-2023 | Ultomiris |
| Amgen INC. | $37.03 | 2023 | Lumakras, Blincyto, Kyprolis |
| Sumitomo Pharma America, INC. | $35.07 | 2024-2025 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $34.09 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $33.97 | 2024 | Provenge |
| Mirati Therapeutics, INC. | $30.85 | 2023 | Krazati |
| Sun Pharmaceutical Industries INC. | $30.51 | 2025 | |
| Deciphera Pharmaceuticals INC. | $26.90 | 2024 | Qinlock |
| Pharmacyclics LLC, An Abbvie Company | $24.58 | 2023 | Imbruvica |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.31 | 2023 | |
| Genmab U.S., INC. | $23.84 | 2025 | Epkinly |
| G1 Therapeutics, INC. | $22.60 | 2023 | Cosela |
| Sobi, INC | $18.15 | 2025 | |
| Adc Therapeutics America, INC. | $17.57 | 2023 | |
| Rigel Pharmaceuticals, INC. | $17.44 | 2022 | |
| Celgene Corporation | $17.06 | 2022 | |
| Genzyme Corporation | $17.06 | 2025 | |
| Beone Medicines USA, INC. | $16.25 | 2025 | Brukinsa |
| Fennec Pharmaceuticals, INC. | $16.20 | 2025 | Fyarro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.